Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer

NCT02795819 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Study drug no longer being clinically developed by manufacturer

Conditions

Renal Cell Carcinoma
Soft Tissue Sarcoma
Metastatic Disease

Interventions

DRUG: AR-42
DRUG: Pazopanib

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]